Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
Clicks: 29
ID: 271813
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
3.6
/100
12 views
2 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Levosimendan, a calcium sensitizer and potassium channel-opener, is widely appreciated by many specialist heart failure practitioners for its effects on systemic and pulmonary hemodynamics and for the relief of symptoms of acute heart failure. The drug’s ...
| Reference Key |
tschöpe2018cardiovascularlevosimendan
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | S. Bouchez, F. Fedele, G. Giannakoulas, F. Gustafsson, V.-P. Harjola, K. Karason, M. Kivikko, D. von Lewinski, F. Oliva, Z. Papp, J. Parissis, Piero Pollesello, G. Pölzl, C. Tschöpe;S. Bouchez;F. Fedele;G. Giannakoulas;F. Gustafsson;V.-P. Harjola;K. Karason;M. Kivikko;D. von Lewinski;F. Oliva;Z. Papp;J. Parissis;Piero Pollesello;G. Pölzl;C. Tschöpe; |
| Journal | cardiovascular drugs and therapy |
| Year | 2018 |
| DOI |
10.1007/s10557-018-6838-2
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.